Amanote Research
Register
Sign In
Letter: Treatment of Vulval Candidiasis With 5-Fluorocytosine.
BMJ
doi 10.1136/bmj.3.5929.523
Full Text
Open PDF
Abstract
Available in
full text
Date
August 24, 1974
Authors
R J Holt
Publisher
BMJ
Related search
Letter: Chronic Mucocutaneous Candidiasis.
BMJ
5-Fluorocytosine Susceptibility of Pathogenic Fungi in the Presence of Allopurinol: Potential for Improving the Therapeutic Index of 5-Fluorocytosine.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Conversion of 5-Fluorocytosine to 5-Fluorouracil by Human Intestinal Microflora.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Antineoplastic Effect of 5-Fluorocytosine and Cytosine Deaminase on Brain Tumor
Neurologia Medico-Chirurgica
Surgery
Neurology
Complementation Analysis of Resistance to 5-Fluorocytosine in Candida Albicans.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
A Case of Successfully Treated Candida Tropicalis With 5-Fluorocytosine in a Patient of APL
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
The Management of Vulval Itching Caused by Benign Vulval Dermatoses
The Obstetrician & Gynaecologist
Successful Treatment With Candida Immunotherapy in a Woman With Recurrent Vulvovaginal Candidiasis.
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Oral Candidiasis in HIV+ Patients Under Treatment With Protease Inhibitors
Brazilian Oral Research
